Search

Christopher W. Fulton

Examiner (ID: 16699, Phone: (571)272-2242 , Office: P/2855 )

Most Active Art Unit
2855
Art Unit(s)
2859, 3641, 2406, 2899, 2841, 2855, 3108, 2856
Total Applications
3373
Issued Applications
2875
Pending Applications
85
Abandoned Applications
419

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6636412 [patent_doc_number] => 20100035825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'Treatment Of Disease By Inducing Cell Apoptosis' [patent_app_type] => utility [patent_app_number] => 12/189526 [patent_app_country] => US [patent_app_date] => 2008-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 27510 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20100035825.pdf [firstpage_image] =>[orig_patent_app_number] => 12189526 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/189526
Treatment of disease by inducing cell apoptosis Aug 10, 2008 Issued
Array ( [id] => 5416921 [patent_doc_number] => 20090042808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'USE OF MITOCHONDRIA-TARGETED ELECTRON SCAVENGERS AS ANTI-INFLAMMATORY AGENTS' [patent_app_type] => utility [patent_app_number] => 12/188369 [patent_app_country] => US [patent_app_date] => 2008-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12186 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042808.pdf [firstpage_image] =>[orig_patent_app_number] => 12188369 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/188369
Use of mitochondria-targeted electron scavengers as anti-inflammatory agents Aug 7, 2008 Issued
Array ( [id] => 6400954 [patent_doc_number] => 20100305024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'METHODS OF INHIBITING CALCINEURIN WITH APOE ANALOGS' [patent_app_type] => utility [patent_app_number] => 12/671433 [patent_app_country] => US [patent_app_date] => 2008-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 16125 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305024.pdf [firstpage_image] =>[orig_patent_app_number] => 12671433 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/671433
Methods of inhibiting calcineurin with ApoE analogs Jul 30, 2008 Issued
Array ( [id] => 4596217 [patent_doc_number] => 07981911 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Pharmaceutical formulations' [patent_app_type] => utility [patent_app_number] => 12/183507 [patent_app_country] => US [patent_app_date] => 2008-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 9445 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/981/07981911.pdf [firstpage_image] =>[orig_patent_app_number] => 12183507 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/183507
Pharmaceutical formulations Jul 30, 2008 Issued
Array ( [id] => 8232967 [patent_doc_number] => 08198405 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-12 [patent_title] => 'Stabilized alpha helical peptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/182673 [patent_app_country] => US [patent_app_date] => 2008-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 83 [patent_no_of_words] => 19120 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/198/08198405.pdf [firstpage_image] =>[orig_patent_app_number] => 12182673 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/182673
Stabilized alpha helical peptides and uses thereof Jul 29, 2008 Issued
Array ( [id] => 8875815 [patent_doc_number] => 08470781 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-25 [patent_title] => 'Use of effectors of glutaminyl and glutamate cyclases' [patent_app_type] => utility [patent_app_number] => 12/182113 [patent_app_country] => US [patent_app_date] => 2008-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 28 [patent_no_of_words] => 27357 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12182113 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/182113
Use of effectors of glutaminyl and glutamate cyclases Jul 28, 2008 Issued
Array ( [id] => 9832048 [patent_doc_number] => 08940865 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-27 [patent_title] => 'Myocardial peptide, preparation method and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/054229 [patent_app_country] => US [patent_app_date] => 2008-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 7393 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13054229 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/054229
Myocardial peptide, preparation method and uses thereof Jul 14, 2008 Issued
Array ( [id] => 4960592 [patent_doc_number] => 20080275017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'AROMATIC SULFENATES FOR TYPE I PHOTOTHERAPY' [patent_app_type] => utility [patent_app_number] => 12/173235 [patent_app_country] => US [patent_app_date] => 2008-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4690 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20080275017.pdf [firstpage_image] =>[orig_patent_app_number] => 12173235 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/173235
AROMATIC SULFENATES FOR TYPE I PHOTOTHERAPY Jul 14, 2008 Abandoned
Array ( [id] => 5429078 [patent_doc_number] => 20090088388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'Peptides for Use In Treating Obesity' [patent_app_type] => utility [patent_app_number] => 12/168993 [patent_app_country] => US [patent_app_date] => 2008-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19409 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20090088388.pdf [firstpage_image] =>[orig_patent_app_number] => 12168993 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/168993
Peptides for Use In Treating Obesity Jul 7, 2008 Abandoned
Array ( [id] => 4644436 [patent_doc_number] => 08022041 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-20 [patent_title] => 'Prodrug of an ICE inhibitor' [patent_app_type] => utility [patent_app_number] => 12/165838 [patent_app_country] => US [patent_app_date] => 2008-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8036 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/022/08022041.pdf [firstpage_image] =>[orig_patent_app_number] => 12165838 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/165838
Prodrug of an ICE inhibitor Jun 30, 2008 Issued
Array ( [id] => 6352455 [patent_doc_number] => 20100249370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'PROCESS FOR THE PRODUCTION OF PRAMLINTIDE' [patent_app_type] => utility [patent_app_number] => 12/665844 [patent_app_country] => US [patent_app_date] => 2008-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3367 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249370.pdf [firstpage_image] =>[orig_patent_app_number] => 12665844 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/665844
PROCESS FOR THE PRODUCTION OF PRAMLINTIDE Jun 29, 2008 Abandoned
Array ( [id] => 5297051 [patent_doc_number] => 20090011977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Novel Lipopeptides as Antibacterial Agents' [patent_app_type] => utility [patent_app_number] => 12/163225 [patent_app_country] => US [patent_app_date] => 2008-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22475 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20090011977.pdf [firstpage_image] =>[orig_patent_app_number] => 12163225 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/163225
Novel Lipopeptides as Antibacterial Agents Jun 26, 2008 Abandoned
Array ( [id] => 4779349 [patent_doc_number] => 20080287347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Novel Lipopeptides as Antibacterial Agents' [patent_app_type] => utility [patent_app_number] => 12/163299 [patent_app_country] => US [patent_app_date] => 2008-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22463 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20080287347.pdf [firstpage_image] =>[orig_patent_app_number] => 12163299 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/163299
Novel Lipopeptides as Antibacterial Agents Jun 26, 2008 Abandoned
Array ( [id] => 9245534 [patent_doc_number] => 08609814 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-17 [patent_title] => 'Modified globin proteins with altered electron transport pathway' [patent_app_type] => utility [patent_app_number] => 12/452075 [patent_app_country] => US [patent_app_date] => 2008-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 9584 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12452075 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/452075
Modified globin proteins with altered electron transport pathway Jun 25, 2008 Issued
Array ( [id] => 4682799 [patent_doc_number] => 20080249025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Methods and Means For Inhibition of CDK4 Activity' [patent_app_type] => utility [patent_app_number] => 12/133242 [patent_app_country] => US [patent_app_date] => 2008-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18918 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249025.pdf [firstpage_image] =>[orig_patent_app_number] => 12133242 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/133242
Methods and Means For Inhibition of CDK4 Activity Jun 3, 2008 Abandoned
Array ( [id] => 5337867 [patent_doc_number] => 20090054331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'HIGH TEMPERATURE STABLE PEPTIDE FORMULATION' [patent_app_type] => utility [patent_app_number] => 12/129504 [patent_app_country] => US [patent_app_date] => 2008-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7807 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054331.pdf [firstpage_image] =>[orig_patent_app_number] => 12129504 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/129504
High temperature stable peptide formulation May 28, 2008 Issued
Array ( [id] => 8664402 [patent_doc_number] => 08377863 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => 'Peptide pharmaceutical for oral delivery' [patent_app_type] => utility [patent_app_number] => 12/128210 [patent_app_country] => US [patent_app_date] => 2008-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10672 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12128210 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/128210
Peptide pharmaceutical for oral delivery May 27, 2008 Issued
Array ( [id] => 8164513 [patent_doc_number] => 08173605 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-08 [patent_title] => 'Kokumi-imparting agent' [patent_app_type] => utility [patent_app_number] => 12/117027 [patent_app_country] => US [patent_app_date] => 2008-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11895 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/173/08173605.pdf [firstpage_image] =>[orig_patent_app_number] => 12117027 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/117027
Kokumi-imparting agent May 7, 2008 Issued
Array ( [id] => 5404494 [patent_doc_number] => 20090239808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'CALCIUM RECEPTOR ACTIVATOR' [patent_app_type] => utility [patent_app_number] => 12/117041 [patent_app_country] => US [patent_app_date] => 2008-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8079 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239808.pdf [firstpage_image] =>[orig_patent_app_number] => 12117041 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/117041
Calcium receptor activator May 7, 2008 Issued
Array ( [id] => 6339638 [patent_doc_number] => 20100247482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'TIGHT JUNCTION MODULATOR PEPTIDES FOR ENHANCED MUCOSAL DELIVERY OF THERAPEUTIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/108452 [patent_app_country] => US [patent_app_date] => 2008-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14338 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247482.pdf [firstpage_image] =>[orig_patent_app_number] => 12108452 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/108452
TIGHT JUNCTION MODULATOR PEPTIDES FOR ENHANCED MUCOSAL DELIVERY OF THERAPEUTIC COMPOUNDS Apr 22, 2008 Abandoned
Menu